13^th European Pathology Congress

Biography

Dr. Liang Cheng is Professor of Pathology and Urology at the Indiana University School of Medicine, Indianapolis, Indiana, USA. Currently, he is the Chief of the Genitourinary Pathology Service, Director of the Urologic Pathology Fellowship, and Director of Molecular Diagnostics and Molecular Pathology Laboratories. Dr. Cheng is board certified in Molecular Genetic Pathology and Anatomic and Clinical Pathology by the American Board of Pathology. Dr. Cheng graduated from Beijing Medical University. Dr. Cheng completed his pathology residency at Case Western Reserve University, Cleveland, Ohio and his fellowship at the Mayo Clinic, Rochester, Minnesota in 1998. Dr. Cheng has received numerous prestigious awards including the Stowell-Orbison Award from the United States and Canadian Academy of Pathology (USCAP) and the Koss Medal Award from the International Society of Urological Pathology (ISUP). In 2006, he was the Arthur Purdy Stout Prize recipient from the Arthur Purdy Stout Society of Surgical Pathologists. Dr. Cheng has published more than 500 peer-reviewed articles in high-impact scientific journals and established a record for the greatest number of abstract presentations (36) in the history of the United States and Canadian Academy of Pathology (USCAP), accounting for 2.3% (36/1551) of total abstracts accepted in the 2004 annual meeting in Vancouver. He was also the author of over 50 book chapters and several books, including “Molecular Genetic Pathology”, “Essentials of Anatomic Pathology”, “Urologic Surgical Pathology”, “Bladder Pathology”, and “Atlas of Genitourinary Pathology”. Currently, he is an active member of over 25 editorial boards, including Molecular Cancer, European Journal of Cancer, American Journal of Surgical Pathology, Modern Pathology, Human Pathology, Journal of Clinical Pathology, Future Oncology, Urologic Oncology, Expert Review of Anticancer Therapy, Critical Review Hematology Oncology. Dr. Chengs research focuses on molecular genetics and biological predictors of genitourinary cancers.

Research Interest

Advances in molecular and cellular biology of prostate tumors ,Development of new therapeutic strategies for advanced prostate cancer,Development of an effective gene therapy for prostate cancer in animal model systems